The Dafalgan tablets from Galenica AG - Swiss everyday pain relief with simple dosing

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-29, 09:10. Details in the imprint.

The Dafalgan tablets from Galenica AG sit in countless Swiss kitchen drawers, a small red-and-white box that people reach for when a headache slowly tightens behind the eyes. You tear the foil, push out the smooth white tablet, and it slides down easily with a sip of water.

What Dafalgan is made for

Dafalgan is a paracetamol-based analgesic and antipyretic, designed for mild to moderate pain such as headache, dental pain, or musculoskeletal aches, and for lowering fever. The standard adult tablet contains 500 mg of paracetamol, while higher-dose formats like 1,000 mg tablets are also offered for specific indications.

In Switzerland the brand is part of a long-established pain portfolio under Galenica, with formulations ranging from classic tablets to effervescent tablets and pediatric preparations. Pharmacists often highlight Dafalgan to patients who need a well-known option without ibuprofen's anti-inflammatory profile, particularly for those with stomach sensitivity.

How it feels in daily use

In everyday use the Dafalgan tablet feels deliberately neutral: no strong taste, a clean, almost chalky surface that softens quickly on the tongue before swallowing. Users often appreciate that one or two tablets, spaced through the day, fit into a routine without demanding much thought about dosing complexity.

During an internal training session captured in Galenica material, pharmacist and trainer Martin Bühler described Dafalgan as a "household anchor" and stressed the importance of clear dosage advice to avoid exceeding the maximum daily amount. That emphasis on guidance reflects the company’s focus on self-medication products that still require responsible use.

Strengths and limits

The obvious strength of Dafalgan is its straightforward positioning: people know it as paracetamol, and the pack clearly states the dose and the maximum daily amount in simple language. That reduces uncertainty for consumers who just want to calm a throbbing headache or bring down a fever without browsing an entire shelf of alternatives.

The limitation is baked into the same simplicity. Paracetamol does not address inflammation as directly as ibuprofen or diclofenac, so for twisted ankles or sports injuries doctors often suggest other options. For patients with liver issues, physicians like Dr. Claudia Huber from a Bern practice reportedly caution that any paracetamol, including Dafalgan, must be used sparingly and strictly within medical guidance.

Where it sits in Galenica's portfolio

Dafalgan sits alongside other consumer health brands in Galenica's non-prescription range, complementing cough remedies, cold treatments, and vitamin products in pharmacies and drugstores across Switzerland. The brand gives the group a visible presence right on the shelf, not just behind the scenes in distribution and pharmacy networks.

Galenica’s CEO Marc Werner has emphasized in recent communications that strengthening own brands in pain and self-care is part of the strategy to balance service revenues with higher-margin products. Dafalgan, with its decades-long recognition, remains one of the pillars supporting that approach in the domestic market.

Stock and company context

Galenica AG is listed on SIX Swiss Exchange under ISIN CH0025536027 and operates an integrated model spanning logistics, pharmacies, and consumer health brands such as Dafalgan. On recent trading days, the Galenica share price has reflected this mix of stable healthcare demand and ongoing portfolio development rather than short-term product headlines.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.